ES2053477T3 - Vacuna viva para enfermedades contagiosas de pollos. - Google Patents
Vacuna viva para enfermedades contagiosas de pollos.Info
- Publication number
- ES2053477T3 ES2053477T3 ES87110291T ES87110291T ES2053477T3 ES 2053477 T3 ES2053477 T3 ES 2053477T3 ES 87110291 T ES87110291 T ES 87110291T ES 87110291 T ES87110291 T ES 87110291T ES 2053477 T3 ES2053477 T3 ES 2053477T3
- Authority
- ES
- Spain
- Prior art keywords
- chicken
- live vaccine
- contagious diseases
- infectious laryngotracheitis
- live
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/245—Herpetoviridae, e.g. herpes simplex virus
- A61K39/255—Marek's disease virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/245—Herpetoviridae, e.g. herpes simplex virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16311—Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
- C12N2710/16334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/816—Viral vaccine for avian species, e.g. poultry or other birds
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biotechnology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
LA INVENCION SE REFIERE A UNA VACUNA VIVA PARA LARINGOTRAQUEITIS INFECCIOSA, QUE CONSISTE EN UN CULTIVO DE CELULAS INFECTADAS CON VIRUS DE LARINGOTRAQUEITIS INFECCIOSA ATENUADO. TAMBIEN SE REFIERE A UNA VACUNA COMBINADA VIVA PARA LARINGOTRAQUEITIS INFECCIOSA Y ENFERMEDAD DE MAREK, QUE CONSISTE EN UN CULTIVO DE CELULAS INFECTADAS CON VIRUS ATENUADOS DE ESTAS DOS ENFERMEDADES. ESTAS VACUNAS SE PUEDEN USAR CON POLLOS DE UN DIA (RECIEN NACIDOS), POR INYECCION SUBCUTANEA O INTRAMUSCULAR, PARA DARLES INMUNIDAD FRENTE AL VIRUS O LOS VIRUS QUE CONTIENEN.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP61170188A JPS6327437A (ja) | 1986-07-17 | 1986-07-17 | 鶏伝染病生ワクチン |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2053477T3 true ES2053477T3 (es) | 1994-08-01 |
Family
ID=15900313
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES87110291T Expired - Lifetime ES2053477T3 (es) | 1986-07-17 | 1987-07-16 | Vacuna viva para enfermedades contagiosas de pollos. |
Country Status (9)
Country | Link |
---|---|
US (1) | US4980162A (es) |
EP (1) | EP0253389B1 (es) |
JP (1) | JPS6327437A (es) |
KR (1) | KR940010022B1 (es) |
AT (1) | ATE86119T1 (es) |
CA (1) | CA1292689C (es) |
DE (1) | DE3784397T2 (es) |
ES (1) | ES2053477T3 (es) |
GR (1) | GR3007856T3 (es) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU647404B2 (en) * | 1989-08-01 | 1994-03-24 | Pfizer Australia Pty Ltd | Low virulence laryngotracheitis (ILT) virus for vaccinating birds |
US5436005A (en) * | 1989-08-01 | 1995-07-25 | Arthur Webster Pty. Ltd. | Low virulence infectiouns laryngotracheitis (ILT) virus for vaccinating birds |
US5279965A (en) * | 1991-04-05 | 1994-01-18 | Keeler Jr Calvin L | Recombinant infectious laryngotracheitis virus |
US5443831A (en) * | 1991-10-29 | 1995-08-22 | University Of Delaware | Gene encoding glycoprotein B of Infectious Laryngotracheitis Virus |
US5443982A (en) * | 1993-07-13 | 1995-08-22 | Solvay Animal Health, Inc. | Methods for the cultivation of infectious laryngotracheitis virus |
AU7838694A (en) * | 1993-09-24 | 1995-04-10 | Syntro Corporation | Recombinant infectious laryngotracheitis virus and uses thereof |
US6984728B2 (en) | 1993-09-24 | 2006-01-10 | Schering Corporation | Recombinant infectious laryngotracheitis virus and uses thereof |
JPH09508005A (ja) * | 1994-01-11 | 1997-08-19 | コーネル リサーチ ファンデーション インコーポレイテッド | 潜伏と腫瘍細胞発生の阻害によるマレク病の抑制 |
CN111542337A (zh) * | 2017-12-20 | 2020-08-14 | 英特维特国际股份有限公司 | 用于细胞相关联的α疱疹病毒疫苗的改良稀释剂 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3331736A (en) * | 1963-02-11 | 1967-07-18 | Schering Corp | Modified laryngotracheitis vaccine |
US3444293A (en) * | 1964-08-24 | 1969-05-13 | Vineland Poultry Lab | Multifunctional laryngotracheitis vaccine and method of making the same |
US3642574A (en) * | 1970-04-29 | 1972-02-15 | Us Agriculture | Method for producing vaccine for immunization of poultry against marek{3 s disease |
ZA743771B (en) * | 1973-07-19 | 1975-07-30 | M Sevoian | Vaccine and preparation thereof |
US3981771A (en) * | 1973-07-19 | 1976-09-21 | Martin Sevoian | Marek's disease vaccine |
JPS57167925A (en) * | 1981-04-08 | 1982-10-16 | Handai Biseibutsubiyou Kenkyukai | Preparation of mixed vaccine for domestic fowl |
-
1986
- 1986-07-17 JP JP61170188A patent/JPS6327437A/ja active Granted
-
1987
- 1987-07-16 DE DE8787110291T patent/DE3784397T2/de not_active Expired - Fee Related
- 1987-07-16 ES ES87110291T patent/ES2053477T3/es not_active Expired - Lifetime
- 1987-07-16 CA CA000542285A patent/CA1292689C/en not_active Expired - Fee Related
- 1987-07-16 US US07/074,148 patent/US4980162A/en not_active Expired - Lifetime
- 1987-07-16 EP EP87110291A patent/EP0253389B1/en not_active Expired - Lifetime
- 1987-07-16 KR KR1019870007688A patent/KR940010022B1/ko not_active IP Right Cessation
- 1987-07-16 AT AT87110291T patent/ATE86119T1/de not_active IP Right Cessation
-
1993
- 1993-05-14 GR GR930400341T patent/GR3007856T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
GR3007856T3 (es) | 1993-08-31 |
ATE86119T1 (de) | 1993-03-15 |
JPS6327437A (ja) | 1988-02-05 |
CA1292689C (en) | 1991-12-03 |
DE3784397D1 (de) | 1993-04-08 |
KR940010022B1 (ko) | 1994-10-20 |
EP0253389B1 (en) | 1993-03-03 |
EP0253389A1 (en) | 1988-01-20 |
US4980162A (en) | 1990-12-25 |
JPH0317807B2 (es) | 1991-03-11 |
KR880001808A (ko) | 1988-04-27 |
DE3784397T2 (de) | 1993-06-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO871313D0 (no) | Fremgangsmaate for fremstilling av virusvaksine. | |
GR3019112T3 (en) | Porcine reproductive respiratory syndrome vaccine and diagnostic. | |
DE3882599T2 (de) | Hundecoronavirus-Impfstoff. | |
ES2053477T3 (es) | Vacuna viva para enfermedades contagiosas de pollos. | |
ATE109007T1 (de) | Zellfreies marekskrankheitvirus-vakzin. | |
NZ228232A (en) | Live combined vaccine comprising at least one live infectious bronchitis virus and at least one other virus infectious to poultry | |
EP0496787A4 (en) | Novel infectious bursal disease virus | |
NZ192271A (en) | Inactivated feline infectious peritonitis (fip) vaccine | |
GR861842B (en) | Infectious bronchitis vaccines for a day-old chickens | |
DE60114908D1 (de) | Hühner-Anäemie-Virus mit geringer Pathogenität |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 253389 Country of ref document: ES |